|
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.
|
May 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
The myelodysplastic syndrome as a prototypical epigenetic disease.
|
May 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Epigenetic alterations and microRNAs: New players in the pathogenesis of myelodysplastic syndromes.
|
May 2013
|
Epigenetics
|
myelodysplastic syndromes (MDS)
|
|
Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison?
|
May 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability.
|
May 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
New insight into myelodysplastic syndromes and related myeloid disorders.
|
May 2013
|
Rinsho Ketsueki
|
myelodysplastic syndromes (MDS)
|
|
Aplastic Anemia & MDS International Foundation: Bone marrow failure disease scientific symposium 2012
|
May 2013
|
Leuk Res
|
aplastic anemia
|
|
Prognostic value of telomere attrition in patients with aplastic anemia.
|
May 2013
|
Leuk Res
|
aplastic anemia
|
|
Myelodysplastic syndromes.
|
May 2013
|
Am Soc Clin Oncol Educ Book
|
myelodysplastic syndromes (MDS)
|
|
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry.
|
May 2013
|
Int J Hematol
|
myelodysplastic syndromes (MDS)
|
